Abstract: Substituted 4-aminoquinazoline derivatives which are inhibitors of gastric acid secretion. A compound of the invention is ethyl 8-methoxy-4-(4-methyl-3-thienyl-amino)quinoline-3-carboxylate.
Type:
Grant
Filed:
February 23, 1989
Date of Patent:
April 9, 1991
Assignee:
Smith Kline & French Laboratories Ltd.
Inventors:
Robert J. Ife, Thomas H. Brown, Colin A. Leach
Abstract: Substituted 4-aminothienopyridine derivatives which are inhibitors of gastric acid secretion. A compound of the invention is 6-butyryl-7-(2-isopropylphenylamino)-thieno[3,2-b]pyridine.
Type:
Grant
Filed:
February 23, 1989
Date of Patent:
June 19, 1990
Assignee:
SmithKline Beckman Intercredit B.V.
Inventors:
Robert J. Ife, Thomas H. Brown, Colin A. Leach
Abstract: This invention relates to chemical compounds which have selective thyromimetic activity. A compound of this invention is 3,5-dibromo-3'-[6-oxo-3(1H)-pyridazinylmethyl]-thyronine.
Type:
Grant
Filed:
March 16, 1988
Date of Patent:
March 20, 1990
Assignee:
Smith Kline & French Laboratories Limited
Inventors:
David Ellis, John C. Emmett, Anthony H. Underwood, Paul D. Leeson
Abstract: New compounds which have potent V.sub.2 -vasopressin antagonistic activity are prepared by a 1,6-cyclization using peptide bond formation. The structures of the compounds are characterized by a Pas.sup.1,6 or Tas.sup.1,6 cyclized unit. Also a chiral synthesis of the optically pure Pas intermediates is described.
Type:
Grant
Filed:
May 9, 1988
Date of Patent:
March 13, 1990
Assignee:
SmithKline Beckman Corporation
Inventors:
James F. Callahan, William F. Huffman, Kenneth A. Newlander, Nelson C. F. Yim
Abstract: The invention relates to pyridazinone derivatives which have inotropic, vasodilator and bronchodilator activity. The compounds of the invention are described by formula (I): ##STR1## wherein: R.sup.1 is hydrogen or methyl;R.sup.2 is hydrogen or methyl; and represent double or single bonds; and the benzene ring is para- or meta-substituted; and pharmaceutically acceptable salts thereof.
Type:
Grant
Filed:
July 1, 1986
Date of Patent:
February 27, 1990
Assignee:
Smith Kline & French Laboratories Limited
Abstract: This invention relates to 2-pyridine derivatives substituted in the 4-position with a dialkylamino- or piperidinyl- or pyrrolidinylalkyl group. The compounds have histamine H.sub.2 -antagonist activity.
Type:
Grant
Filed:
April 19, 1988
Date of Patent:
January 16, 1990
Assignee:
Smith Kline & French Laboratories Limited
Abstract: This invention relates to purinone derivatives which have bronchodilator, vasodilator and anti-allergic activities. A compound of the invention is 2-(2-propoxyphenyl)-6-purinone.
Type:
Grant
Filed:
January 27, 1988
Date of Patent:
December 5, 1989
Assignee:
Smith Kline & French Laboratories Limited
Abstract: Carboxamide derivatives of glcopeptide antibiotics and their salts are useful for treating or preventing infection in an animal by gram-positive bacteria and also increase feed-utilization efficiency, promote growth in domestic animals and increase propionate production in lactating ruminants.
Abstract: Vasopressin-like peptide whose structures have been modified by an alpha-methyl amino acid at the 4 or 7 position are set forth. These compounds have potent vasopressin antagonist activities.
Abstract: This invention relates to alkanoic acid compounds having phenyl and thio substituents which are useful as leukotriene antagonists and pharmaceutical compositions containing such compounds. This invention also relates to treating diseases in which leukotrienes are a factor by administration of an effective amount of the above compounds or compositions.
Type:
Grant
Filed:
March 25, 1988
Date of Patent:
October 17, 1989
Assignee:
Smithkline Beckman Corporation
Inventors:
John G. Gleason, Ralph F. Hall, Thomas W. Ku, Carl D. Perchonock
Abstract: A novel process for preparing alkoxyalkylidenehydrazinopyridazine derivatives which comprises reducing a novel alkoxytriphenylmethylazopyridazine derivative, removing the triphenylmethyl group and reacting with an aldehyde or ketone derivative.A specific compound produced by this process is 3-[3-[[2-(3,4-dimethoxyphenyl)ethyl]amino]-2-hydroxypropoxy]-6-isopropylid enehydrazinopyridazine.
Type:
Grant
Filed:
January 5, 1988
Date of Patent:
October 10, 1989
Assignee:
I.S.F. Societa Per Azioni
Inventors:
Carlo Farina, Mario Pinza, Alberto Cerri, Francesco Parravicini
Abstract: A method for inhibiting the effects of LTB.sub.4 comprises administration of an effective amount of a compound represented by the following structural formula (I) ##STR1## wherein m is 1 or 2; n is 1, 2 or 3; p is 0, 1, or 2; R' is hydrogen or methyl; R is phenyl substituted with A, R.sub.1 and R.sub.2 wherein R.sub.1 and R.sub.2 are independently selected from either (1) (S).sub.a --(CH.sub.2).sub.b --(T).sub.c --B wherein a is 0 or 1; b is 5 to 12; c is 0 or 1; S and T are independently sulfur, oxygen, or CH.sub.2 with the proviso that S or T are not sulfur when p is 1 or 2; and B is C.sub.1-4 alkyl, ethynyl, trifluoromethyl, or phenyl optionally monosubstituted with Br, Cl, CF.sub.3, C.sub.1-4 alkoxy, C.sub.1-4 alkyl, methylthio, or trifluoromethylthio; or (2) hydrogen bromo, chloro, methyl, trifluoromethyl, methoxy or nitro; and A is selected from (2) as defined above or a pharmaceutically acceptable salt thereof. Such methods are useful in the treatment of diseases in which LTB.sub.4 is a factor.
Type:
Grant
Filed:
February 4, 1988
Date of Patent:
October 3, 1989
Assignee:
SmithKline Beckman Corporation
Inventors:
John G. Gleason, Sylvia T. Hoffstein, Charles M. Kinzig, Seymour Mong, Henry M. Sarau
Abstract: The invention relates to 4-hydroxy pyrrolidone derivatives which help restore learning and memory difficulties associated with ageing. A compound of the invention is 2-(4-hydroxy-2-oxo-1-pyrrolidineacetamido)acetamide.
Type:
Grant
Filed:
January 23, 1989
Date of Patent:
September 19, 1989
Assignee:
I.S.F. Societa Per Azioni
Inventors:
Mario Pinza, Carlo Farina, Silvano Banfi, Ugo Pfeiffer
Abstract: The invention relates to thiadiazinone derivatives that have utility as cardiac stimulants. A compound of the invention is 7-(1H-imidazol-1-yl)-9,9a-dihydroindeno[1,2-e][1,3,4]-thiadiazin-2(3H)-one .
Type:
Grant
Filed:
January 29, 1988
Date of Patent:
August 29, 1989
Assignee:
Smith Kline & French Laboratories Limited